A modular approach for integrative analysis of large-scale gene-expression and drug-response data

Nature Biotechnology

Volumn 26, Issue 5, 2008, Pages 531-539

  Kutalik, Zoltán ^a   Beckmann, Jacques S ^a,b   Bergmann, Sven ^a  

^a UNIVERSITY OF LAUSANNE   (Switzerland)

^b LAUSANNE UNIVERSITY HOSPITAL   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

ALGORITHMS; DATA REDUCTION; DATABASE SYSTEMS; DRUG DELIVERY; GENE EXPRESSION;

BIOLOGICAL SAMPLES; DRUG-GENE ASSOCIATIONS; DRUG-RESPONSE DATA;

LARGE SCALE SYSTEMS;

ARTICLE; CELL LINE; COMPUTER MODEL; GENE EXPRESSION; GENE MAPPING; GENETIC ALGORITHM; GENETIC ANALYSIS; GENETIC DATABASE; HIGH THROUGHPUT SCREENING; MICROARRAY ANALYSIS; PREDICTION; PRIORITY JOURNAL;

ALGORITHMS; BIOLOGICAL ASSAY; COMPUTER SIMULATION; DRUG EVALUATION, PRECLINICAL; GENE EXPRESSION PROFILING; MODELS, BIOLOGICAL; PHARMACEUTICAL PREPARATIONS; SIGNAL TRANSDUCTION; SYSTEMS INTEGRATION;

EID: 43449088832     PISSN: 10870156     EISSN: 15461696     Source Type: Journal    
DOI: 10.1038/nbt1397     Document Type: Article

References (48)

1. Benson, M. & Breitling, R. Network theory to understand microarray studies of complex diseases. Curr. Mol. Med. 6, 695-701 (2006).
2. Pereira-Leal, J.B., Enright, A.J. & Ouzounis, C.A. Detection of functional modules from protein interaction networks. Proteins 54, 49-57 (2004).
3. Wang, W., Cherry, J.M., Botstein, D. & Li, H. A systematic approach to reconstructing transcription networks in Saccharomyces cerevisiae. Proc. Natl. Acad. Sci. USA 99, 16893-16898 (2002).
4. Werner, T. Regulatory networks: linking microarray data to systems biology. Mech. Ageing Dev. 128, 168-172 (2007).
5. Alter, O., Brown, P.O. & Botstein, D. Singular value decomposition for genomewide expression data processing and modeling. Proc. Natl. Acad. Sci. USA 97, 10101-10106 (2000).
6. Gasch, A.P. & Eisen, M.B. Exploring the conditional coregulation of yeast gene expression through fuzzy k-means clustering. Genome Biol. 3, RESEARCH0059 (2002).
7. Getz, G., Gal, H., Kela, I., Notterman, D.A. & Domany, E. Coupled two-way clustering analysis of breast cancer and colon cancer gene expression data. Bioinformatics 19, 1079-1089 (2003).
8. Holter, N.S. et al. Fundamental patterns underlying gene expression profiles: simplicity from complexity. Proc. Natl. Acad. Sci. USA 97, 8409-8414 (2000).
9. Ihmels, J. et al. Revealing modular organization in the yeast transcriptional network. Nat. Genet. 31, 370-377 (2002).
10. Segal, E., Yelensky, R. & Koller, D. Genome-wide discovery of transcriptional modules from DNA sequence and gene expression. Bioinformatics 19 Suppl 1, i273-i282 (2003).
11. Tanay, A., Sharan, R., Kupiec, M. & Shamir, R. Revealing modularity and organization in the yeast molecular network by integrated analysis of highly heterogeneous genomewide data. Proc. Natl. Acad. Sci. USA 101, 2981-2986 (2004).
12. Weinstein, J.N. et al. An information-intensive approach to the molecular pharmacology of cancer. Science 275, 343-349 (1997).
13. Staunton, J.E. et al. Chemosensitivity prediction by transcriptional profiling. Proc. Natl. Acad. Sci. USA 98, 10787-10792 (2001).
14. Shankavaram, U.T. et al. Transcript and protein expression profiles of the NCI-60 cancer cell panel: an integromic microarray study. Mol. Cancer Ther. 6, 820-832 (2007).
15. Gaur, A. et al. Characterization of microRNA expression levels and their biological correlates in human cancer cell lines. Cancer Res. 67, 2456-2468 (2007).
16. Bussey, K.J. et al. Integrating data on DNA copy number with gene expression levels and drug sensitivities in the NCI-60 cell line panel. Mol. Cancer Ther. 5, 853-867 (2006).
17. Scherf, U. et al. A gene expression database for the molecular pharmacology of cancer. Nat. Genet. 24, 236-244 (2000).
18. Bergmann, S., Ihmels, J. & Barkai, N. Iterative signature algorithm for the analysis of large-scale gene expression data. Phys. Rev. E 67, 031902 (2003).
19. Ihmels, J., Bergmann, S., Berman, J. & Barkai, N. Comparative gene expression analysis by differential clustering approach: application to the Candida albicans transcription program. PLoS Genet. 1, e39 (2005).
20. Prelic, A. et al. A systematic comparison and evaluation of biclustering methods for gene expression data. Bioinformatics 22, 1122-1129 (2006).
21. Ihmels, J., Bergmann, S. & Barkai, N. Defining transcription modules using large-scale gene expression data. Bioinformatics 20, 1993-2003 (2004).
22. Bergmann, S., Ihmels, J. & Barkai, N. Similarities and differences in genome-wide expression data of six organisms. PLoS Biol. 2, E9 (2004).
23. Ihmels, J. et al. Rewiring of the yeast transcriptional network through the evolution of motif usage. Science 309, 938-940 (2005).
24. Ashburner, M. et al. Gene ontology: tool for the unification of biology. The Gene Ontology Consortium. Nat. Genet. 25, 25-29 (2000).
25. Paull, K.D. et al. Display and analysis of patterns of differential activity of drugs against human tumor cell lines: development of mean graph and COMPARE algorithm. J. Natl. Cancer Inst. 81, 1088-1092 (1989).
26. Ma, Y. et al. Predicting cancer drug response by proteomic profiling. Clin. Cancer Res. 12, 4583-4589 (2006).
27. Gao, F., Foat, B.C. & Bussemaker, H.J. Defining transcriptional networks through integrative modeling of mRNA expression and transcription factor binding data. BMC Bioinformatics 5, 31 (2004).
28. Liu, X., Jessen, W.J., Sivaganesan, S., Aronow, B.J. & Medvedovic, M. Bayesian hierarchical model for transcriptional module discovery by jointly modeling gene expression and ChIP-chip data. BMC Bioinformatics 8, 283 (2007).
29. Segal, E., Friedman, N., Koller, D. & Regev, A. A module map showing conditional activity of expression modules in cancer. Nat. Genet. 36, 1090-1098 (2004).
30. Segal, E. et al. Module networks: identifying regulatory modules and their conditionspecific regulators from gene expression data. Nat. Genet. 34, 166-176 (2003).
31. Wishart, D.S. et al. DrugBank: a comprehensive resource for in silico drug discovery and exploration. Nucleic Acids Res. 34, D668-D672 (2006).
32. Lamb, J. et al. The Connectivity Map: using gene-expression signatures to connect small molecules, genes, and disease. Science 313, 1929-1935 (2006).
33. Zweig, M.H. & Campbell, G. Receiver-operating characteristic (ROC) plots: a fundamental evaluation tool in clinical medicine. Clin. Chem. 39, 561-577 (1993).
34. Kanehisa, M. et al. From genomics to chemical genomics: new developments in KEGG. Nucleic Acids Res. 34, D354-D357 (2006).
35. Hayot, C. et al. Characterization of the activities of actin-affecting drugs on tumor cell migration. Toxicol. Appl. Pharmacol. 211, 30-40 (2006).
36. Melkonian, G. et al. Capillary plexus development in the day five to day six chick chorioallantoic membrane is inhibited by cytochalasin D and suramin. J. Exp. Zool. 292, 241-254 (2002).
37. Marot, D. et al. High tumoral levels of Kiss1 and G-protein-coupled receptor 54 expression are correlated with poor prognosis of estrogen receptor-positive breast tumors. Endocr. Relat. Cancer 14, 691-702 (2007).
38. Hu, J., Zhou, G.B., Wang, Z.Y., Chen, S.J. & Chen, Z. Mutant transcription factors and tyrosine kinases as therapeutic targets for leukemias: from acute promyelocytic leukemia to chronic myeloid leukemia and beyond. Adv. Cancer Res. 98, 191-220 (2007).
39. Neri, L.M. et al. The phosphoinositide 3-kinase/AKT1 pathway involvement in drug and all-trans-retinoic acid resistance of leukemia cells. Mol. Cancer Res. 1, 234-246 (2003).
40. Samuels, Y. & Velculescu, V.E. Oncogenic mutations of PIK3CA in human cancers. Cell Cycle 3, 1221-1224 (2004).
41. Chomienne, C. et al. All-trans retinoic acid modulates the retinoic acid receptor-alpha in promyelocytic cells. J. Clin. Invest. 88, 2150-2154 (1991).
42. Harris, A.L. & Hochhauser, D. Mechanisms of multidrug resistance in cancer treatment. Acta Oncol. 31, 205-213 (1992).
43. Hande, K.R. Etoposide pharmacology. Semin. Oncol. 19, 3-9 (1992).
44. Depeille, P., Cuq, P., Passagne, I., Evrard, A. & Vian, L. Combined effects of GSTP1 and MRP1 in melanoma drug resistance. Br. J. Cancer 93, 216-223 (2005).
45. Breedveld, P. et al. The effect of low pH on breast cancer resistance protein (ABCG2)-mediated transport of methotrexate, 7-hydroxymethotrexate, methotrexate diglutamate, folic acid, mitoxantrone, topotecan, and resveratrol in in vitro drug transport models. Mol. Pharmacol. 71, 240-249 (2007).
46. Doyle, L.A. et al. An etoposide-resistant lung cancer subline overexpresses the multidrug resistance-associated protein. Br. J. Cancer 72, 535-542 (1995).
47. Tavazoie, S., Hughes, J.D., Campbell, M.J., Cho, R.J. & Church, G.M. Systematic determination of genetic network architecture. Nat. Genet. 22, 281-285 (1999).
48. Gamberoni, G., Storari, S. & Volinia, S. Finding biological process modifications in cancer tissues by mining gene expression correlations. BMC Bioinformatics 7, 6 (2006).